Perrigo | Bruttoavancen På Salg



Gross Profit On Sales Lave om Dato
AbbVie USD 10.71B 458M 2024-12
Abbott USD 6.03B 93M 2024-12
Bayer EUR 6.01B 1.13B 2024-12
Bristol-Myers Squibb USD 9.13B 94M 2024-12
Corcept Therapeutics USD 178.93M 745K 2024-12
Dr.Reddys Laboratories INR 49.05B 7.66B 2024-12
Eli Lilly USD 11.13B 1.86B 2024-12
J&J USD 15.41B 102M 2024-12
Merck USD 11.92B 852M 2024-12
Nestle CHF 21.43B 10.71B 2024-12
Pacira USD 147.37M 17.66M 2024-12
Perrigo USD 385.9M 18.5M 2024-12
Pfizer USD 12.11B 718M 2024-12
Prestige Brands USD 161.05M 3.67M 2024-12
Reckitt Benckiser GBP 4.25B 2.08B 2024-12
Sanofi EUR 10.07B 2.1B 2024-09
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
Teva Pharmaceutical Industries USD 2.12B 85M 2024-12
Xeris Pharmaceuticals USD 40.67M 400K 2024-09
Zoetis USD 1.61B 79M 2024-12



Perrigo Bruttoavancen På Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.